Role of Nanostructured Materials in the Treatment of Superficial Yeast Infections

  • Mahendra Rai
  • Alka Yadav


The rising fungal infections are a major cause of public health concern. With the advancements in the clinical field, the life span of the people all over the world has increased. But in the recent decades, the microbes have also developed resistance to a considerable number of traditional and modern drugs specially bacteria and fungi. Among the various virulent properties of microbes is their ability to form biofilm, which is directly related to its ability to cause infections and increase disease severity. Superficial skin infections caused by yeast mainly include oral candidiasis and vaginal candidiasis caused by Candida albicans and other non-albicans species. Candida can occur both as yeast and filamentous fungi. However, most of the Candida species have become resistant to traditionally available drugs like amphotericin B, fluconazole, itraconazole, etc. Nanoparticles combined with antifungal drugs have emerged as a drug delivery system to combat infections. Hence, this chapter deals with the superficial skin infections caused by yeast, different applications of nanotechnology, the role of nanoparticles in the treatment of infections and various nanoformulations developed as nanomedicine for the treatment of yeast infections.


Infections Fungi Candida albicans Nanoparticles Applications Nanoformulations 


  1. Bhardwaj V, Kaushik A (2017) Biomedical applications of nanotechnology and nanomaterials. Micromachines 8:298CrossRefGoogle Scholar
  2. Burdusel AC, Gherasim O, Grumezescu AM, Mogoanta L, Ficai A, Andronescu E (2018) Biomedical applications of silver nanoparticles: an up-to-date review. Nanomaterials 8:681CrossRefGoogle Scholar
  3. Castillo HAP, Castellanos LNM, Chamorro RM, Martinez RR, Borunda EO (2018) In: Sandai D (ed) Nanoparticles as new therapeutic agent against Candida albicans. IntechOpen, London. Scholar
  4. Ficociello G, De Caris MG, Trillo G, Cavallini D, Sarto MS, Uccelletti D, Mancini P (2018) Anti-candidal activity and in vitro cytotoxicity assessment of graphene nanoplatelets decorated with zinc oxide nanorods. Nanomaterials 8:752CrossRefGoogle Scholar
  5. Flores JM, Castillo VB, Franco FC, Huata AB (2009) Superficial fungal infections: clinical and epimediological study in adolescents from marginal districts Lima and Callao, Peru. J Infect Dev Ctries 3(4):313–317CrossRefGoogle Scholar
  6. Ghosh S (2019) Green synthesis of nanoparticles and fungal infection. Scholar
  7. Hsieh YH, Chuang WC, Yu KH, Jheng CP, Lee CI (2019) Sequential photodynamic therapy with Phthalocyanine encapsulated chitosan-tripolyphospahte nanoparticles and flucytosine treatment against Candia tropicalis. Pharmaceutics 11(16):1–11Google Scholar
  8. Jain A, Jain S, Rawat S (2010) Emerging fungal infections among children: a review on its clinical manifestations, diagnosis, and prevention. J Pharm Bioallied Sci 2(4):314–320CrossRefGoogle Scholar
  9. Jeevanandam J, Chan YS, Danquah MK (2016) Nano-formulations of drugs: recent developments, impact and challenges. Biochimie 128-129:99–112CrossRefGoogle Scholar
  10. Keuk-Jun K, Sung SW, Moon SK, Choi JS, Kim JC, Lee DG (2008) Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 18(8):1482–1484Google Scholar
  11. Khadka S, Sherchand JB, Pokharel DB, Pokhrel BM, Mishra SK, Dhital S, Rijal B (2016) Clinicomycological characterization of superficial mycoses from a tertiary care hospital in Nepal. Dermatol Res Pract 9509705:1–8CrossRefGoogle Scholar
  12. Khan S, Alam F, Azam A, Khan AU (2012) Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int J Nanomedicine 7:3245–3257CrossRefGoogle Scholar
  13. Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano-Jimenez MJ, Jose-Yacaman M (2015) Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study. J Nanobiotechnol 13:91CrossRefGoogle Scholar
  14. Levya-Gomez G, Pinon-Segundo E, Mendoza-Munoz N, Zambrano-Zaragoza ML, Mendoza-Elvira S, Quintanar-Guerrero D (2018) Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art. Int J Mol Sci 19:1549CrossRefGoogle Scholar
  15. Macherla C, Sanchez DA, Ahmadi MS, Vellozzi EM, Friedman AJ, Nosanchuk JD, Martinez LR (2012) Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections. Front Microbiol 3:193CrossRefGoogle Scholar
  16. Marcano RGJV, Tominaga TT, Khalil NM, Pedroso LS, Mainardes RM (2018) Chitosan functionalized poly (Ɛ-caprolactone) nanoparticles for Amphotericin-B delivery. Carbohydr Polym 202:345–354CrossRefGoogle Scholar
  17. McNamara K, Tofail SAM (2016) Nanoparticles in biomedical applications. Adv Phys X 2(1):54–88Google Scholar
  18. Muthu Lakshmi NV, Poojitha C, Swarajyalakshmi B (2017) Applications of nanotechnology in medical field. Int J Adv Sci Technol Eng Manage Sci 3(3):5–11Google Scholar
  19. Niemirowicz K, Bucki R (2017) Enhancing the fungicidal activity of antibiotics: are magnetic nanoparticles the key? Nanomedicine 12(15):1747–1749CrossRefGoogle Scholar
  20. Niemirowicz K, Durnas B, Tokajuk G, Piktel E, Michalak G, Gu X, Kulakowska A, Savage PB, Bucki R (2017) Formulation and Candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. Sci Rep 7:4610–4622CrossRefGoogle Scholar
  21. Perera J, Weerasekera M, Kottegoda N (2015) Slow release anti-fungal skin formulations based on citric acid intercalated layered double hydroxides nanohybrids. Chem Cent J 9:27CrossRefGoogle Scholar
  22. Perinelli DR, Campana R, Skouras A, Bonacucina G, Cespi M, Mastrotto F, Baffone W, Casettari L (2018) Chitosan loaded into a hydrogel delivery system as a strategy to treat vaginal co-infection. Pharmaceutics 10:23CrossRefGoogle Scholar
  23. Radhakrishnan SV, Mudiam MKR, Kumar M, Dwivedi SP, Singh SP, Prasad T (2018) Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans). Int J Nanomedicine 13:2647–2663CrossRefGoogle Scholar
  24. Raghuvanshi N, Kumari P, Srivastava AK, Vashisth P, Yadav TC, Prasad R, Pruthi V (2017) Synergistic effects of Woodfordia fruticosa gold nanoparticles in preventing microbial adhesion and accelerating wound healing in Wistar albino rats in vivo. Mater Sci Eng C 80:252–262CrossRefGoogle Scholar
  25. Raj I, Mozetic M, Jayachandran VP, Jose J, Thomas S, Kalarikkal N (2018) Fracture resistant, antibiofilm adherent, self assembled PMMA/ZnO nanoformulations for biomedical applications: physico-chemical and biological perspectives of nano reinforcement. Nanotechnology 29:305704CrossRefGoogle Scholar
  26. Ramos AP, Cruz MAE, Tovani CB, Ciancaglini P (2017) Biomedical applications of nanotechnology. Biophys Rev 9:79–89CrossRefGoogle Scholar
  27. Ramos MADS, Da Silva PB, Sposito L, Bonifacio BV, Rodero CF, Dos Santos KC, Chorilli M, Bauab TM (2019) Nanotechnology based drug delivery systems for control of microbial biofilms: a review. Int J Nanomedicine 13:1179–1213CrossRefGoogle Scholar
  28. Ronavari A, Igaz N, Gopisetty MK, Szerencses B, Kovacs D, Papp C, Vagvolgyi C, Boros IM, Konya Z, Kiricsi M, Pfeiffer I (2018) Biosynthesized silver and gold nanoparticles are potent antimycotics against opportunistic pathogenic yeasts and dermatophytes. Int J Nanomedicine 13:695–703CrossRefGoogle Scholar
  29. Saji VS, Choe HC, Yeung KWK (2010) Nanotechnology in biomedical applications: a review. Int J Nanotechnol Biomater 3(2):119–139CrossRefGoogle Scholar
  30. Santos MM, Amaral S, Harmen SP, Joseph HM, Fernandes JL, Counahan ML (2010) The prevalence of common skin infections in four districts Timor-Leste: a cross sectional survey. BMC Infect Dis 10:61–67CrossRefGoogle Scholar
  31. Sonia S, Linda JKH, Ruckmani K, Sivakumar M (2017) Antimicrobial and antioxidant potentials of biosynthesized colloidal zinc oxide nanoparticles for a fortified cold cream formulation: a potent nanocosmeceutical application. Mater Sci Eng C 79:581–589CrossRefGoogle Scholar
  32. Spadari CC, da Silva de Bastiani FWM, Lopes LB, Ishida K (2019) Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis. Int J Nanomedicine 14:5187–5199CrossRefGoogle Scholar
  33. Voltan AR, Quindos G, Alarcon KPM, Fusco-Almeida AM, Mendes-Giannini MJS, Chorilli M (2017) Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy. Int J Nanomedicine 11:3715–3730CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mahendra Rai
    • 1
  • Alka Yadav
    • 2
  1. 1.Department of BiotechnologyNanobiotechnology LaboratoryAmravatiIndia
  2. 2.Department of BiotechnologySant Gadge Baba Amravati UniversityAmravatiIndia

Personalised recommendations